Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma: an interim analysis from the prospective GMMG-MM5 trial.
| Image |  |
|---|---|
| Description | scientific article published on 3 April 2015 |
| Author/s |
author: Markus Munder Christian Gerecke Matthias Zeis Mathias Haenel Baerbel Schurich Jan Duerig Marc S Raab Hartmut Goldschmidt Dirk Hose Katja Weisel Thomas Hielscher Anja Seckinger Hans-Walter Lindemann Elias Karl Mai Hans Salwender Maximilian Merz Jens Hillengass Uta Bertsch Ingo G H Schmidt-Wolf Christof Scheid |
| Publication date | April 3, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |